Stock Market News 11 November 2025

Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft (MSFT) Stock Today — Nov. 11, 2025: Shares Edge Higher as $10B Portugal AI Hub, Patch Tuesday Fixes and New Enterprise AI Deals Dominate Headlines

Updated Nov. 11, 2025 Key takeaways Market snapshot: MSFT price action Microsoft stock traded modestly higher on Tuesday, recently around $508.68, up $2.91 (~0.6%) versus the prior close. The session’s high/low printed near $509.54/$502.44, with intraday volume just under 17

11 November 2025

Artificial Intelligence·Financial Updates·Stock Market

Apple Stock Today (AAPL) — 11/11/2025: Shares Climb as AI-Spending Discipline Wins Fans; Dividend Arrives This Week

Summary: Apple stock pushed higher on Tuesday, November 11, 2025, trading around $275 and up roughly 2% on the day. The move keeps AAPL within sight of its 52‑week high as investors reward Apple’s comparatively restrained AI spending and weigh

11 November 2025

Apple Inc·Artificial Intelligence·Dividends·Investing·Stock Market

Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna (MRNA) News Today—November 11, 2025: UBS Sees 2026 Upside, Redburn Cuts PT to $36, Bernstein Stays Market Perform After Cost Cuts

Published: November 11, 2025 Moderna, Inc. (NASDAQ: MRNA) drew multiple analyst headlines today as Wall Street recalibrated views in the wake of last week’s earnings and ongoing cost‑cutting. UBS highlighted potential 2026 upside on pipeline and expense discipline; Redburn Atlantic

11 November 2025

Company Updates·Financial Analysis·Investment News·Pharmaceuticals·Stock Market

Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) Today — Nov. 11, 2025: $10B Metsera Deal Nears Vote, Oncology Game Plan Expands, Shares Rise

Updated Nov. 11, 2025 Key takeaways Where the Metsera deal stands today Pfizer has agreed to acquire Metsera on final terms worth up to $10 billion, paying $65.60 in cash per share plus up to $20.65 per share in CVRs

11 November 2025

Business News·Mergers & Acquisitions·Pharmaceuticals·Stock Market

Leifras (NASDAQ: LFS) Rockets on November 11, 2025: Top Gainer Status, Quiet‑Period Countdown, and What’s Driving the Surge

Leifras (LFS) ripped higher on Nov. 11, 2025, topping U.S. gainers as its IPO quiet period nears an end. Here’s what changed today—and what to watch next. Key takeaways What happened today (Tuesday, November 11, 2025) Shares of Leifras Co.,

11 November 2025

Financial Analysis·Investment Strategies·Market Movers·Stock Market

Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Merck (MRK) Rallies on Nov. 11, 2025: FDA Approves New Keytruda Companion Diagnostic; Fresh SITC Combo Data, and Dow Momentum

Published: November 11, 2025 At a glance (today) Market move: MRK helps lead the Dow’s advance By early afternoon Tuesday, Merck & Co. (NYSE: MRK) shares were up about 3.9%, helping lead the Dow Jones Industrial Average higher; Nike and

11 November 2025

Cancer Research·FDA Approvals·Pharma News·Stock Market

Sky on Fire Tonight: Giant ‘Solar Canyon’ Aims 800‑km/s Wind at Earth—Northern Lights Could Ignite 15 U.S. States & Test Global Tech

NOAA Issues G4 ‘Severe’ Geomagnetic Storm Watch for Nov. 12 After X5.1 Solar Flare — Northern Lights Possible as Far South as Indiana Tonight (Nov. 11)

Published: November 11, 2025 Key takeaways What changed today (Nov. 11) NOAA’s Space Weather Prediction Center (SWPC) posted a G4 (Severe) watch for Nov. 12, citing multiple coronal mass ejections (CMEs) now en route — including the most energetic, linked

11 November 2025

Stock Market

GSK (GSK) news today — Nov 11, 2025: New AN2 TB collaboration, buyback activity filed, shares test 12‑month high

GSK plc (NYSE: GSK; LSE: GSK) generated several headlines today: a fresh research tie‑up in tuberculosis drug discovery, confirmation of ongoing share repurchases via a new U.K. regulatory filing, and a U.S.‑listed share price that pushed to a new 12‑month

11 November 2025

Company News·Pharmaceuticals·Stock Market

Vor Biopharma (VOR) Prices $100M Stock Offering at $10; Shares Slide as Investors Weigh Dilution — Nov. 11, 2025

What happened today Vor Biopharma Inc. (NASDAQ: VOR) priced an underwritten public offering of 10 million common shares at $10.00 per share for $100 million in expected gross proceeds. The company granted underwriters a 30‑day option to purchase up to

11 November 2025

Biotech·Financial News·Investments·Stock Market

LivePerson (LPSN) Soars After Citron Shout‑Out: Q3 Beat, Guidance Lift, and AI ‘Conversation Simulator’ Fuel Rally — 11/11/2025

LivePerson, Inc. (NASDAQ: LPSN) jumped sharply on Tuesday after a bullish note from Citron Research added fuel to momentum from the company’s third‑quarter results released late Monday. As of mid‑afternoon, shares traded near $6.25 and touched an intraday high of

11 November 2025

Artificial Intelligence·Earnings Reports·Investment Analysis·Stock Market·Technology News

Supply@ME Capital (LON: SYME) today — 11 Nov 2025: No new RNS; AGM confirmed for 4 Dec as shares trade around 0.004p

Updated Tuesday, 11 November 2025 (UK time). Key takeaways Share price today (11 Nov 2025) In mid‑session dealing, SYME traded around 0.004p, with bid/ask at 0.003p/0.005p and an intraday range of 0.0035p to 0.0045p. Reported turnover was ~629.7 million shares.

11 November 2025

Company News·Investments·Share Price·Stock Market

The RealReal (REAL) spikes to new highs after Q3 beat; Wall Street lifts targets to $15–$16 — all the news investors need today (Nov. 11, 2025)

The luxury resale leader topped Q3 estimates Monday and raised guidance. By Tuesday, shares hit fresh 52‑week highs as BTIG, UBS, Northland, KeyBanc and Baird updated calls. The RealReal, Inc. (NASDAQ: REAL) extended Monday evening’s earnings momentum into Tuesday’s session,

11 November 2025

Earnings Reports·Financial News·Investing·Stock Market·Wall Street